av/casi-pharmaceuticals--big.svg

COM:CASIPHARMACEUTICALS

CASI Pharmaceuticals

  • Stock

USD

Last Close

5.29

22/11 21:00

Market Cap

87.38M

Beta: -

Volume Today

16.02K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
23.73K
-
47.71K
101.09%
4.13M
-
15.14M
266.52%
30.17M
99.25%
43.11M
42.89%
33.88M
21.41%
cost of revenue
7.47K
-
6.27K
15.98%
3.94M
-
9.51M
141.63%
12.56M
32.07%
15.83M
26.04%
14.89M
5.89%
gross profit
16.26K
-
41.44K
154.85%
196K
-
5.63M
2,773.98%
17.61M
212.64%
27.28M
54.90%
18.98M
30.41%
selling and marketing expenses
3.10M
-
7.82M
151.85%
14.71M
88.16%
14.33M
2.58%
general and administrative expenses
2.99M
-
3.76M
25.61%
3.12M
16.99%
4.78M
53.13%
3.16M
33.90%
18.00M
470.22%
27.34M
51.89%
19.66M
28.08%
23.77M
20.88%
23.45M
1.33%
selling general and administrative expenses
2.99M
-
3.76M
25.61%
3.12M
16.99%
4.78M
53.13%
3.16M
33.90%
18.00M
470.22%
30.44M
69.13%
27.48M
9.73%
38.47M
40.02%
37.77M
1.81%
41.84M
10.75%
research and development expenses
2.75M
-
2.77M
0.58%
4.08M
47.37%
4.65M
13.99%
7.60M
63.49%
8.51M
12.01%
9.75M
14.58%
11.47M
17.67%
14.42M
25.74%
16.00M
10.91%
8.79M
45.03%
other expenses
5K
-
82K
1,540%
558K
580.49%
44K
92.11%
cost and expenses
5.74M
-
6.53M
13.75%
7.20M
10.27%
9.42M
30.84%
10.75M
14.13%
26.50M
146.52%
44.12M
66.47%
48.45M
9.82%
65.45M
35.08%
69.60M
6.34%
65.53M
5.85%
operating expenses
5.74M
-
6.52M
13.62%
7.19M
10.30%
9.42M
30.95%
10.75M
14.13%
26.50M
146.52%
40.19M
51.62%
38.95M
3.09%
52.89M
35.81%
53.77M
1.66%
50.63M
5.84%
interest expense
-1.66K
-
28.06K
1,792.64%
82.45K
193.81%
33.81K
59.00%
14.98K
55.70%
8.21K
45.19%
-1.06M
13,038.60%
28.98M
-
ebitda
-5.72M
-
-6.46M
12.82%
-7.08M
9.71%
-9.35M
31.95%
-10.62M
13.60%
-24.79M
133.44%
-31.40M
26.69%
-16.21M
48.38%
-32.03M
97.61%
-7.63M
76.17%
-27.91M
265.58%
operating income
5.74M
-
26.19M
356.23%
7.15M
72.69%
9.42M
31.71%
-10.75M
214.13%
-26.50M
146.52%
-39.99M
50.88%
-33.31M
16.70%
-35.28M
5.91%
-26.49M
24.92%
-31.65M
19.46%
depreciation and amortization
17.39K
-
48.18K
177.07%
68.38K
41.93%
66.45K
2.82%
117.78K
77.24%
1.67M
1,318.70%
8.59M
414.14%
17.11M
99.10%
3.25M
80.98%
18.86M
479.53%
3.74M
80.16%
total other income expenses net
-11.48M
-
-19.67M
71.37%
27.51K
100.14%
-6.79K
124.67%
-19.89K
193.03%
-1.01M
4,963.14%
-5.37M
433.31%
-14.20M
164.35%
-560K
96.06%
-10.94M
1,853.57%
5.35M
148.94%
income before tax
-5.74M
-
-26.20M
356.62%
-7.21M
72.50%
-9.45M
31.18%
-10.77M
13.93%
-27.47M
155.07%
-45.36M
65.12%
-47.51M
4.74%
-35.84M
24.56%
-37.43M
4.43%
-26.29M
29.76%
income tax expense
-11.48M
-
28.06K
100.24%
82.45K
193.81%
33.81K
59.00%
14.98K
55.70%
-958.91K
6,503.00%
6.05M
730.50%
15.06M
149.02%
1.93M
87.18%
1.98M
2.59%
-81K
104.09%
net income
-5.74M
-
-26.20M
356.62%
-7.21M
72.50%
-9.45M
31.18%
-10.77M
13.93%
-27.47M
155.07%
-51.41M
87.13%
-62.57M
21.71%
-37.77M
39.63%
-39.41M
4.34%
-26.94M
31.65%
weighted average shs out
2.61M
-
2.86M
9.45%
3.24M
13.47%
5.59M
72.19%
6.15M
10.10%
8.48M
37.78%
9.59M
13.21%
11.05M
15.12%
13.61M
23.23%
13.65M
0.27%
13.36M
2.10%
weighted average shs out dil
2.61M
-
2.86M
9.45%
3.24M
13.47%
5.59M
72.19%
6.15M
10.10%
8.48M
37.78%
9.59M
13.21%
11.05M
15.12%
13.61M
23.23%
13.65M
0.27%
13.36M
2.10%
eps
-2.20
-
-9.16
316.36%
-2.22
75.76%
-1.69
23.87%
-1.75
3.55%
-3.24
85.14%
-5.36
65.43%
-5.66
5.60%
-2.78
50.88%
-2.89
3.96%
-2.02
30.10%
epsdiluted
-2.20
-
-9.16
316.36%
-2.22
75.76%
-1.69
23.87%
-1.75
3.55%
-3.24
85.14%
-5.36
65.43%
-5.66
5.60%
-2.78
50.88%
-2.89
3.96%
-2.02
30.10%

All numbers in USD (except ratios and percentages)